Refenesen Chest Congestion Relief

Product NDC
10956-791
11-digit product format
109560791
Labeler code
10956
Product ID
10956-791_f6290f7a-6bb6-4686-aaf6-ffc3df8400d4
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin/phenylephrine
Dosage form
TABLET
Route
ORAL
Labeler
Reese Pharmaceutical Co
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2006-02-20
Marketing end
0000-00-00
Substance
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
400 mg/1; mg/1
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct10956-791IInactivated by FDA2026-10-15
excluded packagepackage10956-79110956-791-01IInactivated by FDA2026-10-15
excluded packagepackage10956-79110956-791-01IInactivated by FDA2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage10956-791-01d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage10956-791-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage10956-791-01f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage10956-791-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage10956-791-012ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage10956-791-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage10956-791-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage10956-791-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage10956-791-01cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage10956-791-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage10956-791-01cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage10956-791-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage10956-791-01302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage10956-791-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage10956-791-01ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage10956-791-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage10956-791-010efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage10956-791-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage10956-791-01ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage10956-791-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage10956-791-01367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage10956-791-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage10956-791-01557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage10956-791-01557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage10956-791-018af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage10956-791-018af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage10956-791-01834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage10956-791-01834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage10956-791-011332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage10956-791-011332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage10956-791-01fb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage10956-791-01fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage10956-791-0186f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage10956-791-0186f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage10956-791-01bd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage10956-791-01bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage10956-791-018dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage10956-791-018dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage10956-791-01e2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage10956-791-01e2bbac7714bc…27bdfed8d636…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10956-791-012020-01-31C16284748780-19d75b9d0-307f-f424-e053-dadaa90a57ceDRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10956-791-01Refenesen Chest Congestion Reliefpe1 in 1 CARTONTABLET11
10956-791-09Refenesen Chest Congestion Reliefpe100 in 1 BOTTLE, PLASTICTABLET1001
10956-791-50Refenesen Chest Congestion Reliefpe50 in 1 BOTTLE, PLASTICTABLET501

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10956-791-50EA - Each10956-7919758424c-e3f5-40f8-9344-8387976aa38d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GuaifenesinACTIVE INGREDIENT495W7451VQREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
GuaifenesinACTIVE MOIETY495W7451VQREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48REFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98GREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
MAGNESIUM SILICATEINACTIVE INGREDIENT9B9691B2N9REFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30REFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1
POVIDONEINACTIVE INGREDIENTFZ989GH94EREFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10956-791REFENESEN CHEST CONGESTION RELIEF PE (GUAIFENESIN/PHENYLEPHRINE) TABLET [REESE PHARMACEUTICAL CO]1Legacy NDC, 3 package rows20110119_d917dd8c-ee34-4ccc-b192-cafafc73ce22.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1304111guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral TabletPSNd917dd8c-ee34-4ccc-b192-cafafc73ce221
1304111guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral TabletSCDd917dd8c-ee34-4ccc-b192-cafafc73ce221

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
10956-791-01109560791011 in 1 CARTONHistorical
10956-791-0910956079109100 in 1 BOTTLE, PLASTICHistorical
10956-791-501095607915050 in 1 BOTTLE, PLASTICHistorical